| Literature DB >> 25019221 |
Weicang Wang1, Julia Zhu1, Fei Lyu1, Dipak Panigrahy2, Katherine W Ferrara3, Bruce Hammock4, Guodong Zhang5.
Abstract
Epidemiological and pre-clinical studies support the anti-tumor effects of ω-3 PUFAs; however, the results from human trials are mixed, making it difficult to provide dietary guidelines or recommendations of ω-3 PUFAs for disease prevention or treatment. Understanding the molecular mechanisms by which ω-3 PUFAs inhibit cancer could lead to better nutritional paradigms and human trials to clarify their health effects. The ω-3 PUFAs exert their biological activities mainly through the formation of bioactive lipid metabolites. Here we discuss the biology of cyclooxygenase, lipoxygenase and cytochrome P450 enzymes-derived ω-3-series lipid metabolites on angiogenesis, inflammation and cancer.Entities:
Keywords: Cyclooxygenase; Cytochrome P450; Lipoxygenase; ω-3 polyunsaturated fatty acids
Mesh:
Substances:
Year: 2014 PMID: 25019221 PMCID: PMC4306447 DOI: 10.1016/j.prostaglandins.2014.07.002
Source DB: PubMed Journal: Prostaglandins Other Lipid Mediat ISSN: 1098-8823 Impact factor: 3.072